Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme (ECE). Of...
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasma phosphorylated tau and cerebrovascular burden predict emergency department use in dependent older patients.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·2026
Same author

Pragmatic cluster-randomised trial of a multidomain intervention to prevent hospital-acquired disability: the OPTIMAge-IT study protocol.

BMC geriatrics·2026
Same author

Depressive symptoms in older patients undergoing electrical cardioversion of persistent atrial fibrillation. A possible association with clinical complexity, physical performance and inflammation.

European journal of internal medicine·2026
Same author

Tonometer- and ultrasound-based pulse wave analysis - a comparative study.

Computer methods and programs in biomedicine·2026
Same author

Hypertension in autoimmune rheumatic diseases: a position paper from the European Society of Hypertension working group on small arteries. Part A: pathophysiology, prevalence and cardiovascular risk estimation.

Journal of hypertension·2026
Same author

Hypertension in autoimmune rheumatic diseases - a position paper from the European Society of Hypertension working group on small arteries. Part B: Recommendations for the clinical management of hypertension.

Journal of hypertension·2026

Related Experiment Video

Updated: May 27, 2026

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

Hypertension and endothelial dysfunction: therapeutic approach.

Lorenzo Ghiadoni1, Stefano Taddei, Agostino Virdis

  • 1Department of Internal Medicine, University of Pisa, Pisa, Italy. l.ghiadoni@med.unipi.it

Current Vascular Pharmacology
|November 25, 2011
PubMed
Summary

Essential hypertension is linked to endothelial dysfunction, impacting NO availability and increasing cardiovascular risk. Treatments like exercise, diet, and certain medications can improve endothelial function in hypertensive patients.

More Related Videos

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

Related Experiment Videos

Last Updated: May 27, 2026

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

Area of Science:

  • Cardiovascular Research
  • Hypertension Studies
  • Endothelial Function Analysis

Background:

  • Essential hypertension is frequently associated with endothelial dysfunction, characterized by reduced nitric oxide (NO) availability due to increased oxidative stress.
  • Endothelial dysfunction serves as an early indicator of atherosclerosis and a predictor of cardiovascular events in hypertensive individuals.

Purpose of the Study:

  • To review and describe the various techniques used to assess endothelial dysfunction in essential hypertension.
  • To discuss the advantages and limitations of these methodologies in both microcirculation and macrocirculation.
  • To summarize current data on endothelial dysfunction in hypertension and the impact of therapeutic interventions.

Main Methods:

  • Review of existing literature on endothelial function assessment in essential hypertension.
  • Analysis of methodologies for studying microcirculation (resistance arteries, arterioles) and macrocirculation (conduit arteries).
  • Evaluation of data on endothelial dysfunction and treatment effects in coronary and peripheral vascular beds.

Main Results:

  • Endothelial dysfunction in hypertensive patients is linked to target organ damage and predicts cardiovascular events.
  • Non-pharmacological interventions like exercise and diet can improve endothelial function.
  • Certain antihypertensive drugs (calcium channel blockers, ACE inhibitors, AT1 receptor antagonists), nebivolol, and statins show beneficial effects on endothelial function.

Conclusions:

  • Endothelial dysfunction is a significant factor in essential hypertension, contributing to cardiovascular risk.
  • Therapeutic strategies targeting endothelial function, including lifestyle changes and specific medications, hold promise for improving outcomes.
  • Further research is required to confirm the prognostic value of improved endothelial function in hypertensive patients.